Literature DB >> 27193080

An open-label randomised controlled trial on the efficacy of adding intranasal fentanyl to intravenous tramadol in patients with moderate to severe pain following acute musculoskeletal injuries.

Keng Sheng Chew1, Abdul Hafiz Shaharudin1.   

Abstract

INTRODUCTION: The use of intranasal fentanyl as an alternative type of analgesia has been shown to be effective in paediatric populations and prehospital settings. There are a limited number of studies on the use of intranasal fentanyl in adult patients in emergency settings.
METHODS: An open-label study was conducted to evaluate the effectiveness of the addition of 1.5 mcg/kg intranasal fentanyl to 2 mg/kg intravenous tramadol (fentanyl + tramadol arm, n = 10) as compared to the administration of 2 mg/kg intravenous tramadol alone (tramadol-only arm, n = 10) in adult patients with moderate to severe pain due to acute musculoskeletal injuries.
RESULTS: When analysed using the independent t-test, the difference between the mean visual analogue scale scores pre-intervention and ten minutes post-intervention was 29.8 ± 8.4 mm in the fentanyl + tramadol arm and 19.6 ± 9.7 mm in the tramadol-only arm (t[18] = 2.515, p = 0.022, 95% confidence interval 1.68-18.72 mm). A statistically significant, albeit transient, reduction in the ten-minute post-intervention mean arterial pressure was noted in the fentanyl + tramadol arm as compared to the tramadol-only arm (13.35 mmHg vs. 7.65 mmHg; using Mann-Whitney U test with U-value 21.5, p = 0.029, r = 0.48). There was a higher incidence of transient dizziness ten minutes after intervention among the patients in the fentanyl + tramadol arm.
CONCLUSION: Although effective, intranasal fentanyl may not be appropriate for routine use in adult patients, as it could result in a significant reduction in blood pressure. Copyright: © Singapore Medical Association

Entities:  

Keywords:  fentanyl; intranasal drug administration; tramadol

Mesh:

Substances:

Year:  2016        PMID: 27193080      PMCID: PMC5651506          DOI: 10.11622/smedj.2016096

Source DB:  PubMed          Journal:  Singapore Med J        ISSN: 0037-5675            Impact factor:   1.858


  18 in total

1.  Nasal mucociliary clearance as a factor in nasal drug delivery.

Authors: 
Journal:  Adv Drug Deliv Rev       Date:  1998-01-05       Impact factor: 15.470

2.  Interpretation of visual analog scale ratings and change scores: a reanalysis of two clinical trials of postoperative pain.

Authors:  Mark P Jensen; Connie Chen; Andrew M Brugger
Journal:  J Pain       Date:  2003-09       Impact factor: 5.820

Review 3.  Intranasal medication delivery for children: a brief review and update.

Authors:  Timothy R Wolfe; Darren A Braude
Journal:  Pediatrics       Date:  2010-08-09       Impact factor: 7.124

4.  A randomized controlled trial comparing intranasal fentanyl to intravenous morphine for managing acute pain in children in the emergency department.

Authors:  Meredith Borland; Ian Jacobs; Barbara King; Debra O'Brien
Journal:  Ann Emerg Med       Date:  2006-10-25       Impact factor: 5.721

5.  Use of intranasal fentanyl for the relief of pediatric orthopedic trauma pain.

Authors:  Mary Saunders; Kathleen Adelgais; Douglas Nelson
Journal:  Acad Emerg Med       Date:  2010-11       Impact factor: 3.451

Review 6.  Tramadol. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in acute and chronic pain states.

Authors:  C R Lee; D McTavish; E M Sorkin
Journal:  Drugs       Date:  1993-08       Impact factor: 9.546

7.  A randomized controlled trial of intranasal fentanyl vs intravenous morphine for analgesia in the prehospital setting.

Authors:  Claire Rickard; Peter O'Meara; Matthew McGrail; David Garner; Alan McLean; Peter Le Lievre
Journal:  Am J Emerg Med       Date:  2007-10       Impact factor: 2.469

8.  The effect of emergency department crowding on the management of pain in older adults with hip fracture.

Authors:  Ula Hwang; Lynne D Richardson; Tolulope O Sonuyi; R Sean Morrison
Journal:  J Am Geriatr Soc       Date:  2006-02       Impact factor: 5.562

Review 9.  The clinical applications of intranasal opioids.

Authors:  Katherine Shelley; Michael James Paech
Journal:  Curr Drug Deliv       Date:  2008-01       Impact factor: 2.565

10.  Intranasal fentanyl for pain control: current status with a focus on patient considerations.

Authors:  Eric Prommer; Lisa Thompson
Journal:  Patient Prefer Adherence       Date:  2011-03-18       Impact factor: 2.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.